Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of None. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM1 known ✓ | P11229 | 4/20 | 0.70 |
| ▸ | CHRM3 known ✓ | P20309 | 2/20 | 0.70 |
| ▸ | CHRM4 | P08173 | 3/20 | 0.70 |
| ▸ | TSHR | P16473 | 3/20 | 0.70 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.70 |
| ▸ | LMNA | P02545 | 2/20 | 0.70 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.70 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.70 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.70 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.70 |
| ▸ | BLM | P54132 | 3/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.69 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.69 |
| ▸ | MEN1 | O00255 | 1/20 | 0.69 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.68 |
| ▸ | TP53 | P04637 | 1/20 | 0.68 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.58 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL183762 | 0.93 | CHRM1 (0.81) | CHRM1CHRM4TSHRCHRM2LMNA | |
| Hydrochloric Acid SCHEMBL1724312 | 0.92 | KMT2A (0.81) | CHRM1CHRM4TSHRCHRM2LMNA | |
| Scopolamine SCHEMBL892533 | 0.91 | CHRM4 (0.85) | CHRM1CHRM4TSHRCHRM2LMNA | |
| Scopolamine SCHEMBL892536 | 0.91 | CHRM4 (0.85) | CHRM1CHRM4TSHRCHRM2LMNA | |
| Scopolamine SCHEMBL892535 | 0.91 | CHRM4 (0.85) | CHRM1CHRM4TSHRCHRM2LMNA | |
| Scopolamine SCHEMBL31064233 | 0.86 | CHRM4 (0.91) | CHRM1CHRM4TSHRCHRM2LMNA | |
| Scopolamine SCHEMBL22163750 | 0.86 | CHRM4 (0.91) | CHRM1CHRM4TSHRCHRM2LMNA | |
| Scopolamine SCHEMBL22163749 | 0.86 | CHRM4 (0.91) | CHRM1CHRM4TSHRCHRM2LMNA | |
| Scopolamine SCHEMBL3717240 | 0.85 | CHRM4 (0.85) | CHRM1CHRM4TSHRCHRM2LMNA | |
| Scopolamine SCHEMBL28927548 | 0.83 | CHRM1 (0.95) | CHRM1CHRM4TSHRCHRM2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3849347-A1 | LIPOPHILIC ACTIVE AGENT INFUSED TOBACCO LEAVES AND/OR TOBACCO MATERIALS AND METHODS OF USE THEREOF | Poviva Corp. (US) | 2021-07-21 | — | — | EP | disclosed |
| WO-2020056344-A1 | LIPOPHILIC ACTIVE AGENT INFUSED TOBACCO LEAVES AND/OR TOBACCO MATERIALS AND METHODS OF USE THEREOF | POVIVA TEA, LLC (US) | 2020-03-19 | — | — | WO | disclosed |
| WO-2010136219-A1 | ENTERIC COATING | HEXAL AKTIENGESELLSCHAFT (DE) | 2010-12-02 | — | — | WO | disclosed |
| EP-2034953-A2 | ORALLY DISINTEGRATING LAYERED COMPOSITIONS | Capricorn Pharma, Inc. (US) | 2009-03-18 | — | — | EP | disclosed |
| WO-2008002529-A2 | ORALLY DISINTEGRATING LAYERED COMPOSITIONS | CAPRICORN PHARMA, INC. (US) | 2008-01-03 | — | — | WO | disclosed |
| WO-2007062262-A2 | GELATINOUS MEDICAMENT FORMULATION AND METHOD OF ADMINISTRATION | BRAGINSKY PHILIP Y (US) | 2007-05-31 | — | — | WO | disclosed |
| WO-2004050677-A1 | NOVEL CHEMICAL COMPUNDS AND THEIR USE | BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) | 2004-06-17 | — | — | WO | disclosed |
| WO-2003040104-A1 | DIMERIC PHARMACEUTICAL COMPOUNDS AND THEIR USE | BIOTA SCIENTIFIC MANAGEMENT PTY LTD (AU) | 2003-05-15 | — | — | WO | disclosed |